Breaking News Instant updates and real-time market news.

CVS

CVS Health

$68.68

-0.33 (-0.48%)

, AET

Aetna

$177.29

0.22 (0.12%)

11:31
03/13/18
03/13
11:31
03/13/18
11:31

CVS Health stockholders approve Aetna acquisition

In a special meeting, CVS Health Corporation (CVS) stockholders voted to approve the shares of company stock to be issued in the company's acquisition of Aetna (AET). According to the preliminary results announced at the meeting, more than 98% of the shares voted were in favor of the proposal. The merger is expected to close in the second half of 2018, subject to required regulatory approvals.

CVS

CVS Health

$68.68

-0.33 (-0.48%)

AET

Aetna

$177.29

0.22 (0.12%)

  • 13

    Mar

  • 13

    Mar

  • 16

    Apr

  • 30

    May

CVS CVS Health
$68.68

-0.33 (-0.48%)

02/09/18
NEED
02/09/18
NO CHANGE
Target $98
NEED
Strong Buy
CVS Health price target lowered to $98 after earnings at Needham
Needham analyst Kevin Caliendo lowered his price target on CVS Health to $98 from $100 after the company's earnings. Caliendo notes that while the PBM and retail businesses were solid, the negative development of CVS planning to reinvest $1.2B of tax reform windfall in compensation and infrastructure "undermined the positives". The analyst is also concerned with President Trump's budget proposal focusing on curbing drug prices. However, he maintains a Strong Buy rating on CVS shares.
02/14/18
JEFF
02/14/18
NO CHANGE
JEFF
Amazon focusing on bolstering medical device distribution, says Jefferies
Yesterday's Wall Street Journal report and a recent scan of job postings still point to Amazon.com's (AMZN) focus on bolstering its medical device/supplies distribution capabilities, specifically targeting hospitals, Jefferies analyst Brian Tanquilut. These postings support a negative thesis for Cardinal Health (CAH), Owens & Minor (OMI) and Premier's (PINC) medical supplies businesses, the analyst adds. Further, he sees the news as an incremental positive for AmerisourceBergen (ABC), McKesson (MCK), CVS Health (CVS) and Walgreens Boots Alliance (WBA) since it further supports the view that Amazon isn't looking to enter the prescription business near-term.
02/27/18
BOFA
02/27/18
INITIATION
Target $91
BOFA
Buy
CVS Health reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on CVS Health with a Buy and $91 price target.
03/08/18
JEFF
03/08/18
NO CHANGE
Target $91
JEFF
Buy
Jefferies does not expect competing bids for Express Scripts
Jefferies analyst Brian Tanquilut believes Cigna (CI) is paying a fair price for Express Scripts (ESRX) and does not expect competing bids to emerge. The deal is another mark on the ongoing vertical integration wave in Healthcare, Tanquilut tells investors in a research note. The analyst previously stated that Express Script would be the most logical acquisition target for Amazon (AMZN) if the tech giant truly had aspirations of entering the pharmacy retailing market. However, it appears that speculation has quieted down in recent weeks, Tanquilut admits today. Regarding regulatory risk for the Cigna/Express Scripts deal, the analyst believes scrutiny will come mostly from the government's interest in what a large-scale combination of large players from two different healthcare sub-sectors will bring to overall drug costs, patient premiums and out-of-pocket dollars. He highlights the existence of UnitedHealth's (UNH) OptumRx and CVS's (CVS) Caremark. Cigna in morning trading is down 9.5%, or $18.47, to $175.75 while Express Scripts is up 11% to $81.59.
AET Aetna
$177.29

0.22 (0.12%)

01/31/18
PIPR
01/31/18
NO CHANGE
Target $212
PIPR
Overweight
Piper sees buying opportunity in Aetna after yesterday's pullback
Piper Jaffray analyst Sarah James sees a buying opportunity in Aetna (AET) following yesterday's 3% pullback on the Amazon (AMZN), Berkshire (BRK.A) and JPMorgan (JPM) news. The company yesterday morning posted a solid earnings beat driven by strong cost trend management in the government and commercial businesses, James tells investors in a research note. She raised her price target for Aetna shares to $212 from $207 and keeps an Overweight rating on the name. CVS Health's (CVS) takeout offer now values the shares at $212, up from $207 previously, based on 0.8378 shares of CVS stock plus $145 per share in cash, James points out. The analyst sees a "win-win" setup for the stock based on the deal going through or the company remaining standalone.
01/31/18
RBCM
01/31/18
UPGRADE
Target $98
RBCM
Outperform
Express Scripts upgraded to Outperform at RBC Capital
As reported earlier, RBC Capital analyst George Hill upgraded Express Scripts (ESRX) to Outperform and raised his price target to $98 from $68. Hill cites the "recent sharp pullback on Amazon's (AMZN) healthcare entry" de-risking the stock, while also pointing to the trend of vertical integration as seen in the CVS (CVS)-Aetna (AET) deal. The analyst believes Express Scripts could also become an attractive M&A target as "one of the few remaining assets at scale".
01/31/18
FBCO
01/31/18
NO CHANGE
Target $208
FBCO
Neutral
Aetna price target raised to $208 from $200 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for Aetna to $208 from $200, citing on track operationally. However, the analyst is cautious on sustainability of tax benefit. He reiterates a Neutral rating on the shares.
02/01/18
02/01/18
DOWNGRADE
Target $69

Underperform
Express Scripts downgraded to Underperform at Bernstein
As previously reported, Bernstein analyst Lance Wilkes downgraded Express Scripts to Underperform from Market Perform, with a $69 price target, as he believes tax reform is fully price in and his original concerns on the standalone PBM model remain. Further, the analyst sees additional risks from a potential CVS (CVS)/Aetna (AET) merger and Amazon (AMZN) threats.

TODAY'S FREE FLY STORIES

WPP

WPP

$51.13

-0.98 (-1.88%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
WPP to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

DG

Dollar General

$105.63

2.92 (2.84%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Dollar General management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

MGPI

MGP Ingredients

$60.55

-1.02 (-1.66%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
MGP Ingredients management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 17

    Dec

WCN

Waste Connections

$76.66

-0.4 (-0.52%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Waste Connections management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

B

Barnes Group

$55.08

0.54 (0.99%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Barnes Group management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

TAP

Molson Coors

$62.74

-0.65 (-1.03%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Molson Coors to hold a tour »

Molson Coors HQ &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Citigroup to hold a tour »

China Property/Financial…

BLRX

BioLineRx

$0.66

0.005 (0.76%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
BioLineRx to host investor meeting »

Investor Breakfast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

GERN

Geron

$1.41

-0.08 (-5.37%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Geron management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NTES

NetEase

$236.92

0.17 (0.07%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
NetEase management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ROCK

Gibraltar Industries

$34.29

-0.54 (-1.55%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Gibraltar Industries management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ADP

ADP

$139.77

0.44 (0.32%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
ADP management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

AKTS

Akoustis

$5.43

0.1 (1.88%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Akoustis management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Stephens construction analysts to hold an analsyt/industry conference call »

Construction Analysts,…

ACM

Aecom

$28.14

-0.445 (-1.56%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Aecom to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

VISI

Volt Information Sciences

$2.60

-0.04 (-1.52%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Volt Information Sciences to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CPHR

Cipher Pharmaceuticals

$0.00

(0.00%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Cipher Pharmaceuticals to hold an investor webcast »

President & CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CHKP

Check Point

$109.25

2.9 (2.73%)

, EQIX

Equinix

$387.39

0.63 (0.16%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
FBN Securities to hold a bus tour »

Silicon Valley Technology…

CHKP

Check Point

$109.25

2.9 (2.73%)

EQIX

Equinix

$387.39

0.63 (0.16%)

FTNT

Fortinet

$74.70

3.07 (4.29%)

ZS

Zscaler

$40.56

0.17 (0.42%)

FEYE

FireEye

$19.76

0.34 (1.75%)

FSCT

ForeScout

$26.70

0.87 (3.37%)

NTNX

Nutanix

$43.17

1 (2.37%)

SPLK

Splunk

$108.55

2.85 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 13

    Dec

  • 17

    Dec

  • 19

    Dec

  • 19

    Dec

  • 20

    Dec

  • 09

    Jan

  • 10

    Jan

  • 15

    Jan

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Key Banc to hold a tour »

AI & Digital…

FSLR

First Solar

$43.22

0.6 (1.41%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
First Solar to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ARC

ARC Document

$2.30

-0.12 (-4.96%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
ARC Document management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 13

    Dec

SKY

Skyline

$17.52

-0.07 (-0.40%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Skyline management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CONN

Conn's

$23.83

0.09 (0.38%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Conn's management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 13

    Dec

ATGE

Adtalem Global Education

$52.07

-0.7 (-1.33%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Adtalem Global Education management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

OSK

Oshkosh

$63.78

-2.91 (-4.36%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Oshkosh management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.